Your browser doesn't support javascript.
loading
Effective control of SARS-CoV-2 transmission between healthcare workers during a period of diminished community prevalence of COVID-19.
Jones, Nick K; Rivett, Lucy; Sparkes, Dominic; Forrest, Sally; Sridhar, Sushmita; Young, Jamie; Pereira-Dias, Joana; Cormie, Claire; Gill, Harmeet; Reynolds, Nicola; Wantoch, Michelle; Routledge, Matthew; Warne, Ben; Levy, Jack; Córdova Jiménez, William David; Samad, Fathima Nisha Begum; McNicholas, Chris; Ferris, Mark; Gray, Jane; Gill, Michael; Curran, Martin D; Fuller, Stewart; Chaudhry, Afzal; Shaw, Ashley; Bradley, John R; Hannon, Gregory J; Goodfellow, Ian G; Dougan, Gordon; Smith, Kenneth Gc; Lehner, Paul J; Wright, Giles; Matheson, Nicholas J; Baker, Stephen; Weekes, Michael P.
Afiliação
  • Jones NK; Department of Infectious Diseases, Cambridge University NHS Hospitals Foundation Trust, Cambridge, United Kingdom.
  • Rivett L; Clinical Microbiology & Public Health Laboratory, Public Health England, Cambridge, United Kingdom.
  • Sparkes D; Department of Medicine, University of Cambridge, Cambridge, United Kingdom.
  • Forrest S; Cambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID), Jeffrey Cheah Biomedical Centre, Cambridge Biomedical Campus, University of Cambridge, Cambridge, United Kingdom.
  • Sridhar S; Department of Infectious Diseases, Cambridge University NHS Hospitals Foundation Trust, Cambridge, United Kingdom.
  • Young J; Clinical Microbiology & Public Health Laboratory, Public Health England, Cambridge, United Kingdom.
  • Pereira-Dias J; Department of Infectious Diseases, Cambridge University NHS Hospitals Foundation Trust, Cambridge, United Kingdom.
  • Cormie C; Clinical Microbiology & Public Health Laboratory, Public Health England, Cambridge, United Kingdom.
  • Gill H; Department of Medicine, University of Cambridge, Cambridge, United Kingdom.
  • Reynolds N; Cambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID), Jeffrey Cheah Biomedical Centre, Cambridge Biomedical Campus, University of Cambridge, Cambridge, United Kingdom.
  • Wantoch M; Department of Medicine, University of Cambridge, Cambridge, United Kingdom.
  • Routledge M; Cambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID), Jeffrey Cheah Biomedical Centre, Cambridge Biomedical Campus, University of Cambridge, Cambridge, United Kingdom.
  • Warne B; Wellcome Sanger Institute, Hinxton, United Kingdom.
  • Levy J; Academic Department of Medical Genetics, University of Cambridge, Cambridge, United Kingdom.
  • Córdova Jiménez WD; Department of Medicine, University of Cambridge, Cambridge, United Kingdom.
  • Samad FNB; Cambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID), Jeffrey Cheah Biomedical Centre, Cambridge Biomedical Campus, University of Cambridge, Cambridge, United Kingdom.
  • McNicholas C; Department of Medicine, University of Cambridge, Cambridge, United Kingdom.
  • Ferris M; Cambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID), Jeffrey Cheah Biomedical Centre, Cambridge Biomedical Campus, University of Cambridge, Cambridge, United Kingdom.
  • Gray J; Department of Medicine, University of Cambridge, Cambridge, United Kingdom.
  • Gill M; Cambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID), Jeffrey Cheah Biomedical Centre, Cambridge Biomedical Campus, University of Cambridge, Cambridge, United Kingdom.
  • Curran MD; Wellcome - MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, United Kingdom.
  • Fuller S; Department of Haematology, School of Clinical Medicine, University of Cambridge, Cambridge, United Kingdom.
  • Chaudhry A; Department of Infectious Diseases, Cambridge University NHS Hospitals Foundation Trust, Cambridge, United Kingdom.
  • Shaw A; Clinical Microbiology & Public Health Laboratory, Public Health England, Cambridge, United Kingdom.
  • Bradley JR; Department of Infectious Diseases, Cambridge University NHS Hospitals Foundation Trust, Cambridge, United Kingdom.
  • Hannon GJ; Cambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID), Jeffrey Cheah Biomedical Centre, Cambridge Biomedical Campus, University of Cambridge, Cambridge, United Kingdom.
  • Goodfellow IG; Institute for Manufacturing, Department of Engineering, University of Cambridge, Cambridge, United Kingdom.
  • Dougan G; Institute for Manufacturing, Department of Engineering, University of Cambridge, Cambridge, United Kingdom.
  • Smith KG; Institute for Manufacturing, Department of Engineering, University of Cambridge, Cambridge, United Kingdom.
  • Lehner PJ; Improvement and Transformation Team, Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom.
  • Wright G; Occupational Health and Wellbeing, Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom.
  • Matheson NJ; Cancer Research United Kingdom Cambridge Institute, University of Cambridge, Cambridge, United Kingdom.
  • Baker S; Cancer Research United Kingdom Cambridge Institute, University of Cambridge, Cambridge, United Kingdom.
Elife ; 92020 06 19.
Article em En | MEDLINE | ID: mdl-32558644
Assuntos
Técnicas de Laboratório Clínico/estatística & dados numéricos; Infecções por Coronavirus/transmissão; Pessoal de Saúde; Programas de Rastreamento/estatística & dados numéricos; Doenças Profissionais/prevenção & controle; Pandemias; Pneumonia Viral/transmissão; Adulto; Doenças Assintomáticas; Betacoronavirus/genética; Betacoronavirus/isolamento & purificação; COVID-19; Teste para COVID-19; Infecções Comunitárias Adquiridas/transmissão; Busca de Comunicante; Infecções por Coronavirus/diagnóstico; Infecções por Coronavirus/epidemiologia; Infecções por Coronavirus/prevenção & controle; Transmissão de Doença Infecciosa/prevenção & controle; Inglaterra/epidemiologia; Características da Família; Feminino; Unidades Hospitalares; Hospitais de Ensino/organização & administração; Hospitais de Ensino/estatística & dados numéricos; Hospitais Universitários/organização & administração; Hospitais Universitários/estatística & dados numéricos; Humanos; Controle de Infecções; Transmissão de Doença Infecciosa do Paciente para o Profissional/estatística & dados numéricos; Masculino; Programas de Rastreamento/organização & administração; Pessoa de Meia-Idade; Nasofaringe/virologia; Doenças Profissionais/epidemiologia; Pandemias/prevenção & controle; Admissão do Paciente/estatística & dados numéricos; Pneumonia Viral/diagnóstico; Pneumonia Viral/epidemiologia; Pneumonia Viral/prevenção & controle; Prevalência; Avaliação de Programas e Projetos de Saúde; Reação em Cadeia da Polimerase em Tempo Real; SARS-CoV-2; Avaliação de Sintomas
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pneumonia Viral / Programas de Rastreamento / Pessoal de Saúde / Infecções por Coronavirus / Técnicas de Laboratório Clínico / Pandemias / Doenças Profissionais Tipo de estudo: Diagnostic_studies / Evaluation_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies / Screening_studies País/Região como assunto: Europa Idioma: En Revista: Elife Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Reino Unido
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pneumonia Viral / Programas de Rastreamento / Pessoal de Saúde / Infecções por Coronavirus / Técnicas de Laboratório Clínico / Pandemias / Doenças Profissionais Tipo de estudo: Diagnostic_studies / Evaluation_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies / Screening_studies País/Região como assunto: Europa Idioma: En Revista: Elife Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Reino Unido